BYAH Shareholder Alert: Park Ha Biological Technology Co., Ltd. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

GlobeNewswire | SueWallSt
Today at 2:42pm UTC

NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SueWallSt reminds purchasers of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) securities that a class action was filed on behalf of investors who acquired shares between December 27, 2024 and July 8, 2025. Find out if you could qualify to recover your per-share losses. You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt.

BYAH closed at $41.01 on July 7, 2025 and at $2.99 on July 8, 2025, a per-share decline of approximately $38.02, or roughly 93%. The last day to move for lead plaintiff is September 28, 2026.

How Alleged Artificial Inflation Is Measured Per Share

The lawsuit maintains that BYAH shares traded at artificially inflated prices throughout the Class Period and that the single-session repricing on July 8, 2025 reflected the removal of alleged inflation rather than a response to any newly disclosed operating result. Plaintiffs assert that no material corporate development was announced to explain either the stock rise from the $4.00 IPO price or the subsequent collapse.

What Rights Class Members Have

Investors do not need to have sold their shares to be class members, and no action is required to remain an absent class member. Recovery in a securities class action is generally calculated on a per-share basis using documented purchase and sale activity during the Class Period.

  • IPO price of $4.00 per share on December 27, 2024, with 1,200,000 shares sold for approximately $4.8 million in proceeds
  • Class Period high of $41.49 intraday on July 7, 2025, against roughly 26.4 million shares outstanding
  • Closing price of $2.99 on July 8, 2025 on volume exceeding 8.9 million shares
  • Per-share decline of approximately $38.02 in one trading session, or about 93%
  • More than $1 billion in market capitalization erased on July 8, 2025
  • Claims asserted under Sections 11, 12 and 15 of the Securities Act and Sections 10(b) and 20(a) of the Exchange Act

"When companies fail to disclose material information, shareholders may suffer significant losses. Here the complaint alleges that BYAH investors paid prices inflated by promotional activity the Company never addressed, and the $38.02 per-share decline is the measure of that alleged harm." -- Joseph E. Levi, Esq.

Submit your information here or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the BYAH Lawsuit

Q: How much did BYAH stock drop? A: Shares fell approximately 93%, a decline of about $38.02 per share, closing at $2.99 on July 8, 2025 after the single-session collapse that followed an alleged artificial price surge. Investors who purchased during the Class Period at allegedly inflated prices may be eligible to seek compensation.

Q: When did Park Ha allegedly mislead investors? A: The Class Period runs from December 27, 2024 to July 8, 2025. The complaint alleges the July 8, 2025 collapse followed disclosures and events revealing information that caused a significant decline in share value.

Q: Who are the defendants named in the BYAH lawsuit? A: The complaint names Park Ha Biological Technology Co., Ltd. along with individual defendants including senior executives and directors who signed the registration statement, as well as the Company's auditor and IPO underwriters.

Q: What is the BYAH lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is September 28, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without acting before that date.

Q: What if I already sold my BYAH shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible.

Q: What does it cost me to participate? A: There is no upfront cost to contact the firm. Securities class actions are generally handled on a pure contingency basis, with no retainer and no out-of-pocket costs. Any attorneys' fees and expenses awarded to class counsel are subject to court approval.

Q: What do BYAH investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt, a brand of Levi & Korsinsky LLP, for a no-cost, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@SueWallSt.com
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.